Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) Adults

NCT02822547 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

253

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Peginterferon alfa-2a

Sponsor

Yonsei University

Collaborators

[object Object]